Endobronchial indocyanine green instillation to identify the intersegmental plane for successful segmentectomy

The traditional indications for lobectomy for resectable Non‐small Cell Lung Cancer (NSCLC) may be set to change. Recently, anatomical segmentectomy (AS) versus lobectomy as an approach for early‐stage NSCLC has been described in phase 3 randomised controlled trials. The demand for methods to facilitate AS may increase as a consequence. We describe three cases of AS using the combination of endobronchial infiltration of indocyanine green (ICG) to identify the intersegmental plane (critical for the performance of AS), and Computed Tomography (CT) guided methylene blue injection for lesion localisation. The operations were completed successfully demonstrating satisfactory post‐operative outcomes including lesion resection with clear surgical margins and acceptable length of stay. We believe that endobronchial instillation of ICG and CT‐guided methylene blue injection for lesion localisation show promise as a technique to complement parenchymal sparing thoracic oncological surgery.

[1]  K. Orihashi,et al.  Fluorescence visualization of the intersegmental plane by bronchoscopic instillation of indocyanine green into the targeted segmental bronchus: determination of the optimal settings , 2021, The Journal of international medical research.

[2]  Chungyeul Kim,et al.  Evaluation of Intraoperative Near-Infrared Fluorescence Visualization of the Lung Tumor Margin With Indocyanine Green Inhalation. , 2020, JAMA surgery.

[3]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[4]  D. Gossot,et al.  Identification of the intersegmental plane during thoracoscopic segmentectomy: state of the art. , 2019, Interactive cardiovascular and thoracic surgery.

[5]  R. Cerfolio,et al.  Technique, Outcomes with Navigational Bronchoscopy Using Indocyanine Green for Robotic Segmentectomy. , 2019, The Annals of thoracic surgery.

[6]  Haihua Zhang,et al.  Segmentectomy versus Wedge Resection for Stage I Non-Small Cell Lung Cancer: A Meta-analysis. , 2019, The Journal of surgical research.

[7]  Ian M. Paquette,et al.  Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare Databases: Use in Clinical Research for Improving Colorectal Cancer Outcomes , 2019, Clinics in Colon and Rectal Surgery.

[8]  Hua Zhang,et al.  Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer , 2018, OncoTargets and therapy.

[9]  A. Charloux,et al.  Lung segmentectomy: does it offer a real functional benefit over lobectomy? , 2017, European Respiratory Review.

[10]  D. Gossot,et al.  The intersegmental plane: an emerging concern for the thoracoscopic surgeon , 2017 .

[11]  N. Altorki,et al.  Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non–Small Cell Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  J. Dai,et al.  Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis , 2016, Therapeutic advances in respiratory disease.

[13]  T. Yan,et al.  Could less be more?-A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. , 2015, Lung cancer.

[14]  Kathleen A Cronin,et al.  The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. , 2014, Cancer.

[15]  B. Meyers,et al.  Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. , 2013, The Annals of thoracic surgery.

[16]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[17]  H. Sasaki,et al.  Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. , 2007, Lung cancer.

[18]  Teruaki Koike,et al.  Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.

[19]  M. Okada,et al.  Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? , 2001, The Annals of thoracic surgery.

[20]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[21]  W. Warren,et al.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. , 1994, The Journal of thoracic and cardiovascular surgery.

[22]  OUP accepted manuscript , 2021, Interactive Cardiovascular and Thoracic Surgery.

[23]  M. Okada,et al.  Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. , 2005, The Journal of thoracic and cardiovascular surgery.

[24]  E. Heath,et al.  National Institutes of Health , 2019, The Grants Register 2022.